Insights into product and process related challenges of lentiviral vector bioprocessing
Open Access
- 1 August 2023
- journal article
- research article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 121 (8) , 2466-2481
Abstract
Lentiviral vectors (LVs) are used in advanced therapies to transduce recipient cells for long term gene expression for therapeutic benefit. The vector is commonly pseudotyped with alternative viral envelope proteins to improve tropism and is selected for enhanced functional titers. However, their impact on manufacturing and the success of individual bioprocessing unit operations is seldom demonstrated. To the best of our knowledge, this is the first study on the processability of different Lentiviral vector pseudotypes. In this work, we compared three envelope proteins commonly pseudotyped with LVs across manufacturing conditions such as temperature and pump flow and across steps common to downstream processing. We have shown impact of filter membrane chemistry on vector recoveries with differing envelopes during clarification and observed complete vector robustness in high shear manufacturing environments using ultra scale‐down technologies. The impact of shear during membrane filtration in a tangential flow filtration‐mimic showed the benefit of employing higher shear rates, than currently used in LV production, to increase vector recovery. Likewise, optimized anion exchange chromatography purification in monolith format was determined. The results contradict a common perception that lentiviral vectors are susceptible to shear or high salt concentration (up to 1.7 M). This highlights the prospects of improving LV recovery by evaluating manufacturing conditions that contribute to vector losses for specific production systems.Keywords
This publication has 32 references indexed in Scilit:
- Development of Third-generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T-cellsMolecular Therapy, 2016
- Construction of stable packaging cell lines for clinical lentiviral vector productionScientific Reports, 2015
- Lentiviral vectors: basic to translationalBiochemical Journal, 2012
- The Inside Out of Lentiviral VectorsViruses, 2011
- Micro biochemical engineering to accelerate the design of industrial‐scale downstream processes for biopharmaceutical proteinsBiotechnology and Bioengineering, 2008
- Altering the Tropism of Lentiviral Vectors through PseudotypingCurrent Gene Therapy, 2005
- The effect of protein–protein and protein–membrane interactions on membrane fouling in ultrafiltrationJournal of Membrane Science, 2000
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.Proceedings of the National Academy of Sciences, 1993
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984